Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients—Patients' vulnerability still matters

Current meta‐analysis suggests that outcomes with novel oral anticoagulants (NOACs) do not significantly differ compared to vitamin K antagonists (VKAs) after transcatheter aortic valve replacement (TAVR) in patients with atrial fibrillation (AF), in particular, NOACs failed to demonstrate a better...

Descripción completa

Detalles Bibliográficos
Autores principales: Tarantini, Giuseppe, Fraccaro, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Valvular and Structural Heart Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544356/
https://www.ncbi.nlm.nih.gov/pubmed/35674104
http://dx.doi.org/10.1002/ccd.30235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9544356/
https://www.ncbi.nlm.nih.gov/pubmed/35674104
http://dx.doi.org/10.1002/ccd.30235

Ejemplares similares